04/19/2018 | Ben Mead
Simpler to produce and easier to administer than stem cell therapies – are exosomes the answer to our retinal regeneration needs?
04/19/2018 | Kang Zhang
Reprogramming cells to sidestep disease – or turning back the clock on senescent cells in age-related disease? Here’s what we can do today – and what’s on the horizon.
04/19/2018 | Alan Mendelsohn
We need to reinforce the message to stop smoking.
04/19/2018 | Mark Hillen
Might temporary microglia depletion treat inflammatory retinal disease?
04/19/2018 | Ruth Steer
Could a successful treatment for dry AMD be on the horizon?
04/06/2018 | Sponsored by Bayer
The 3rd Global Retinal Network Program Annual Meeting
03/28/2018
The 2018 Power List nominees share their thoughts on the future of ophthalmology.
03/28/2018 | Mark Hillen
Looking into why some patients with early-stage AMD progress to late-stage within five years
03/28/2018 | Ruth Steer
Is gene therapy the answer to an untreatable form of macular degeneration?
03/28/2018 | Napoleone Ferrara
Napoleone Ferrara, Distinguished Adjunct Professor of Ophthalmology, UC San Diego School of Medicine, California, USA.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: